Cutler Group LP Cara Therapeutics, Inc. Transaction History

Cutler Group LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$8.24 - $12.56 $8,240 - $12,560	-1,000 Reduced 62.11%	610 $5,000
Q2 2022 Aug 04, 2022	BUY	$7.45 - $13.84 $2,086 - $3,875	280 Added 21.05%	1,610 $14,000
Q4 2021 Jan 18, 2022	SELL	$11.99 - $18.14 $12,169 - $18,412	-1,015 Reduced 43.28%	1,330 $16,000
Q3 2021 Oct 26, 2021	BUY	$11.55 - $16.06 $27,084 - $37,660	2,345 New	2,345 $36,000
Q3 2020 Oct 27, 2020	SELL	$12.34 - $17.92 $37,020 - $53,760	-3,000 Closed	0 $0

Q1 2020 May 07, 2020	BUY	$9.12 - $17.78 $21,924 - $42,743	2,404 Added 403.36%	3,000 $39,000
Q4 2019 Feb 06, 2020	SELL	$16.11 - $25.98 $11,277 - $18,186	-700 Reduced 54.01%	596 $9,000
Q3 2019 Oct 28, 2019	SELL	$18.28 - $26.91 $25,592 - $37,674	-1,400 Reduced 51.93%	1,296 $23,000
Q2 2019 Aug 09, 2019	BUY	$17.68 - $21.57 $31,824 - $38,826	1,800 Added 200.89%	2,696 $57,000
Q1 2019 May 10, 2019	BUY	$14.41 - $19.64 $7,205 - $9,820	500 Added 126.26%	896 $17,000
Q4 2018 Feb 05, 2019	SELL	$12.45 - $23.47 $4,980 - $9,388	-400 Reduced 50.25%	396 $5,000
Q3 2018 Nov 07, 2018	BUY	$17.57 - $23.95 $3,514 - $4,790	200 Added 33.56%	796 $19,000
Q2 2018 Aug 10, 2018	SELL	$11.6 - $19.27 $32,480 - $53,956	-2,800 Reduced 82.45%	596 $11,000
Q1 2018 May 11, 2018	BUY	$11.77 - $16.08 $15,253 - $20,839	1,296 Added 61.71%	3,396 $42,000
Q4 2017 Jan 17, 2018	SELL	$11.86 - $14.08 $2,372 - $2,816	-200 Reduced 8.7%	2,100 $25,000
Q3 2017 Oct 17, 2017	BUY	$12.6 - $16.34 $28,980 - $37,582	2,300	2,300 $31,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.